Interpace Biosciences Inc logo

Interpace Biosciences Inc

$ 1.65 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 7.04M
Enterprise V:
$ 14.07M
Volume:
300.00
Avg Vol (2M):
3.36K
Also Trade In:
Volume:
300.00
Market Cap $:
7.04M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.36K
Enterprise Value $:
14.07M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Interpace Biosciences Inc is engaged in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It operates under one segment which is the business of developing and selling diagnostic clinical and pharma services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.47
Equity-to-Asset -4.03
Debt-to-Equity -0.22
Debt-to-EBITDA -1.09
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -23.21
Distress
Grey
Safe
Beneish M-Score -7.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63
9-Day RSI 54.42
14-Day RSI 50.5
6-1 Month Momentum % -45.44
12-1 Month Momentum % -75.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.86
Quick Ratio 0.78
Cash Ratio 0.43
Days Inventory 24.55
Days Sales Outstanding 50.29
Days Payable 36.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.5

Financials

IDXG's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IDXG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 45.225
EPS (TTM) ($) -5.7
Beta 0.52
Volatility % 58.45
14-Day RSI 50.5
14-Day ATR ($) 0.196351
20-Day SMA ($) 1.60832
12-1 Month Momentum % -75.27
52-Week Range ($) 1.05 - 9
Shares Outstanding (Mil) 4.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Interpace Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Interpace Biosciences Inc Analysis

Share your research

Headlines

See More
No news.